At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Trivalent Inactivated Influenza vaccinebiological
Likely dose
Trivalent Inactivated Influenza vaccine 0.5 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Examine the Early Cytokine Responses After Inactivated Influenza Vaccination in Adults 18-50.
Johns Hopkins Bloomberg School of Public Health·interventional·Posted Jan 31, 2012·Updated Mar 15, 2019
In Brief
A clinical study evaluating Trivalent Inactivated Influenza vaccine for Influenza Virus Vaccine. Completed, enrolled 20 participants across 1 site.
Detailed Summary
Some people experience symptoms just after receiving the seasonal inactivated influenza vaccine. The cause of some of these symptoms is likely to be an immune response to the vaccine. The investigators would like to look at the earliest immune responses to the inactivated influenza vaccine. This pilot study will help us to determine at what time points we should look.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza Virus Vaccine
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2012
First PostedJan 2012
Primary CompletionFeb 2012
TodayJul 2026
First PostedJan 31, 2012
Enrollment StartJan 1, 2012
Primary CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.4 years ago
Interventions
Trivalent Inactivated Influenza vaccinebiological
0.5 ml IM once only